Cancer Clinical Trials
Your access to cutting-edge cancer treatments.
As a leader in clinical oncology research, our Sharp Center for Research offers you the latest clinical trials that assist in discovery of new and improved treatments to help you overcome cancer. With a wide selection of open trials for almost every tumor site we give you more options for cancer research.
As a participant of a clinical trial, you are guided through the use of experimental drugs or treatments that have been recommended based on your type of cancer. Please visit the links below for additional detailed information about our clinical trials.
Enroll in an active clinical trial.
- NCT01805076 - Breast, sponsored by Alliance for Clinical Trials in Oncology, study drug MRI
- NCT02492711 - Breast, sponsored by MacroGenics, study drug Margetuximab, Trastuzumab
- NCT02513394 - Breast, sponsored by Alliance Foundation Trials, LLC, study drug Palbociclib
- NCT02750826 - Breast, sponsored by Alliance for Clinical Trials in Oncology, no study drug - health education, weight loss intervention
- NCT02927249 - Positive HER2 negative breast cancer, sponsored by Alliance for Clinical Trials in Oncology, study drug aspirin
- NCT02978716 - Breast, sponsored by G1 Therapeutics, Inc., study drug trilaciclib, gemcitabine, carboplatin
- NCT01901094 - Breast, sponsored by Alliance for Clinical Trials in Oncology, axillary lymph node dissection, radiation therapy
- NCT02308085 - Breast, sponsored by Alliance for Clinical Trials in Oncology, endocrine therapy interruption
- NCT02926911 - Breast, sponsored by Alliance Foundation Trials, LLC, study drug, guideline concordant care, active surveillance
- NCT00986661 - Liver, sponsored by Provectus Pharmaceuticals, study drug PV-10
- NCT02659059 - Non-small cell lung cancer, sponsored by Bristol-Myers Squibb, study drug Nivolumab, Ipilimumab
- NCT02713867 - Non-small cell lung cancer, sponsored by Bristol Myers Squibb, study drug Nivolumab
- NCT02288897 - Melanoma, sponsored by Provectus Biopharmaceuticals, Inc., study drug PV-10
- NCT02889900 - Ovarian, sponsored by AstraZeneca, study drug cediranib, olaparib
- NCT01013649 - Pancreatic, sponsored by National Cancer Institute, study drug radiation therapy
- NCT02380274 - Castration-resistant prostate cancer, sponsored by Astellas Scientific & Medical Affairs, Inc.
- NCT02111577 - Metastatic castrate-resistant prostate cancer, sponsored by Sotio a.s., study drug DCVAC-PCa
- NCT01540994 - Prostatic neoplasm, sponsored by Sharp HealthCare, study drug radiation therapy
- NCT02407054 - Metastatic prostate cancer, sponsored by Eli Lilly and Company, study drug LY3023414, Enzalutamide
- NCT02952534 - Metastatic castration resistant prostate cancer, sponsored by Clovis Oncology, Inc., study drug rucaparib
- NCT02975934 - Prostate, sponsored by Clovis Oncology, Inc., study drug rucaparib
- NCT02872714 - Urothelial cancer, sponsored by Incyte Corp., study drug INCB54828
- NCT01772004 - Solid tumors, sponsored by EMD Serono, study drug Avelumab
- NCT02465060 - Solid tumors, sponsored by NCI, study drug - variable
- NCT02157792 - Solid tumors, sponsored by Vertex Pharmaceuticals, study drug - VX-970
- NCT02564900 - Solid tumors, sponsored by Daiichi Sankyo Co., study drug DS-8201a
- NCT02834013 - Rare tumors, sponsored by National Cancer Institute, study drug ipilimumab, nivolumab
Choose the best doctor in San Diego for you.
View doctors specializing in oncology in San Diego.
"I strive to offer excellent cancer care — either in the office, in the hospital or at home."
"I am dedicated to providing exceptional, compassionate cancer care and being an advocate for my patients."
"I provide sensitive, comprehensive care for patients with cancer and blood disorders."
"I am dedicated to providing compassionate and exceptional cancer care to my patients and caring for the whole family"